Skip to main content
user-generated· price

Pharmaceutical industry stock declines by 15% within 12 months of Med…

The introduction of a Medicare for All bill in Congress will trigger a market reaction, with pharmaceutical stocks declining as investors price in potential pricing controls and reduced revenue. The decline will be led by major pharmaceutical companies with significant U.S. revenue exposure.

price · Prediction Market

Implied probability (Yes)
75%
Closes
2027-06-30

More price markets

Browse all price markets →

Loading…